Animal Trypanosomiasis: Challenges and Prospects for New Vaccination Strategies
Microorganisms · 13.12.2024 · 12 (12) · 2575
DOI: 10.3390/microorganisms12122575 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 13.12.2024. Verfasst von Samille Henriques Pereira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado de Minas Gerais—FAPEMIG.
Abstract (Originalsprache)
Animal trypanosomiasis, such as nagana, surra, and dourine, represent a significant challenge to animal health and economic development, especially in tropical and subtropical regions where livestock production is an essential component of a country’s economy. Despite advances in the control of human trypanosomiasis, animal diseases caused by several species of trypanosomes remain neglected. The lack of funding for the development of new treatments and vaccines contributes to sustaining the severe economic impacts these diseases have on the farming industry, especially in low-income rural areas. Recent advances in the understanding of the immune processes involved during infection have been essential for the development of new approaches towards disease control including vaccines. These new approaches must be part of integrated control programs, which must also include vector management and the awareness of good veterinary practices. Addressing the challenges posed by the control of animal trypanosomiasis requires collaborative and continuous efforts shared among scientists, governments, and the farming industry, if significant progress is to be made to mitigate the impact of these diseases. In this literature review, we discuss the main challenges for the development of vaccines for animal trypanosomiasis and the research underway, including the prospects for employing new vaccine platforms, such as an mRNA vaccine, vector-based vaccine, and CRISPR-attenuated parasite vaccine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
- Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte 31310-260, MG, Brazil.
ORCID-Profile: Samille Henriques Pereira, Felipe Paladino Alves, Santuza Maria Ribeiro Teixeira
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- National Council for Scientific and Technological Development
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais—FAPEMIG
- Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq
- CNPq
Zitieren
APA
Pereira, S. H., Alves, F. P., & Teixeira, S. M. R. (2024). Animal Trypanosomiasis: Challenges and Prospects for New Vaccination Strategies. Microorganisms, 12(12), 2575. https://doi.org/10.3390/microorganisms12122575
Vancouver
Pereira SH, Alves FP, Teixeira SMR. Animal Trypanosomiasis: Challenges and Prospects for New Vaccination Strategies. Microorganisms. 2024;12(12):2575. doi:10.3390/microorganisms12122575
BibTeX
@article{Pereira2024,
author = {Pereira, Samille Henriques and Alves, Felipe Paladino and Teixeira, Santuza Maria Ribeiro},
title = {Animal Trypanosomiasis: Challenges and Prospects for New Vaccination Strategies},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {12},
pages = {2575},
doi = {10.3390/microorganisms12122575}
}
EUVIMED